PLAY PODCASTS
Podcast on Addressing Social Determinants: Strategies to Support PrEP Persistence and Reengagement
Episode 342

Podcast on Addressing Social Determinants: Strategies to Support PrEP Persistence and Reengagement

Hear from Beatriz Grinsztejn, MD, PhD, in this case-based discussion on the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women.

Decera Clinical Education Infectious Disease Podcast · Beatriz Grinsztejn MD PhD

November 28, 202315m 27s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Beatriz Grinsztejn, MD, PhD, discusses the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women, including: 

  • HIV prevalence among transgender women
  • Data on the PrEP cascade from the PrEParadas study of daily FTC/TDF among transgender women
  • Data from the ImPrEP Study on early loss to follow-up, adherence, long-term engagement, and HIV incidence among transgender women
  • Barriers to PrEP uptake and adherence for transgender women
  • Drug–drug interactions between PrEP and feminizing hormone therapy
  • Increasing PrEP uptake and retention with peer health navigation for transgender women

Faculty

Beatriz Grinsztejn, MD, PhD
Director
HIV/STI Clinical Research Laboratory
Instituto Nacional de Infectologia Evandro Chagas-Fiocruz
Rio de Janeiro, Brazil
IAS President-Elect

Link to full program:
https://bit.ly/3ZlICsL


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

transgender womenpreparadasbeatriz grinsztejncabotegravirpersistencecabfeminizing hormone therapyhptn 083peer health navigatorlong-acting cabotegravirpeer navigatorpreexposure prophylaxisla cabtenofovir alafenamideprepbarrierstransgender individualstenofovir disoproxil fumarateemtricitabineengagementimprepcab-laftc/tdfdrug-drug interactionskey populationsfhtadherencetenofovirphn